Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Alexion to Acquire Portola
Wednesday, May 06, 2020Alexion Pharmaceuticals Inc and Portola Pharmaceuticals Incannounced that they have entered into a definitive merger agreement for Alexion to acquire Portola a commercialstage biopharmaceutical company focused on lifethreatening bloodrelated disorde...
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatments
Wednesday, May 06, 2020AGC Biologic s a global contract biopharmaceutical manufacturing and development organization CDMO has been selected to commercially manufacture the Clevegen treatment for partner Faron Pharmaceuticals Oy AIM FARN First North FARON a biopharmaceut...
Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19
Tuesday, May 05, 2020Junshi Biosciences and Eli Lilly and Company announced they have entered into an agreement to codevelop therapeutic antibodies for the potential prevention and treatment of COVID the disease caused by the SARSCoV novel coronavirus
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Tuesday, May 05, 2020Arcturus Therapeutics Holdings Inc a leading clinicalstage messenger RNA mRNA medicines and vaccines company and Catalent Inc the leading global provider of advanced delivery technologies development and manufacturing solutions for drugs biologics ce...
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
Monday, May 04, 2020BioMarin Pharmaceutical Inc announced that the company has entered into a preclinical collaboration and license agreement with DiNAQOR AG DiNAQOR a gene therapy platform company to develop novel gene therapies to treat rare genetic cardiomyopathies D...
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO™ Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With Multiple Myeloma
Saturday, May 02, 2020Halozyme Therapeutics Inc announced that its collaborator Janssen Biotech Inc Janssen has received approval from the US Food and Drug Administration FDA for DARZALEX FASPRO daratumumab hyaluronidase human fihj DARZALEX FASPRO is approved in four reg...
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
Saturday, May 02, 2020Moderna Inc a clinical stage biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines to create a new generation of transformative medicines for patients and Lonza Ltd SIX LONN today announced a year strategic collaboration agree...
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic
Friday, May 01, 2020Trio Pharmaceuticals Inc TRIO a cancer therapeutics company developing novel dual action antibody drugs TRIObody and novel dual action antibody drug conjugates TRIObody Drug Conjugate TDC and Ajinomoto BioPharma Services Aji BioPharma a leading provi...
WuXi Biologics and Aravive Form Strategic Collaboration
Friday, May 01, 2020WuXi Biologics a global company with leading openaccess biologics technology platforms and Aravive Inc NASDAQARAV a clinicalstage biopharmaceutical company today announced a strategic collaboration agreement granting Aravive the right to use the prop...
Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19
Thursday, April 30, 2020Atreca Inc BeiGene Ltd and IGM Biosciences Inc Nasdaq IGMS today announced their plans to collaborate to help address the COVID pandemic The companies will leverage their combined technology and expertise in an effort to discover develop and manufact...
